Anderson, Timothy S, Ashley O’Donoghue, Oren Mechanic, Tenzin Dechen, and Jennifer Stevens. 2022. “Administration of Anti-SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization.”. JAMA Network Open 5 (8): e2228997.
Abstract
This cross-sectional study uses time-series data to evaluate the administration of bamlanivimab-etesevimab and casirivimab-imdevimab monoclonal antibody treatments for SARS-CoV-2 infection after the US Food and Drug Administration deauthorized their use in early 2022.